Mini Review
Published on 05 Nov 2021
Impact of Andropause on Multiple Sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2021.766308
- 6,775 views
- 6 citations
Type at least 3 characters
1,123 articles
Original Research
Published on 03 Nov 2021
Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Neuromyelitis Optica Spectrum Disorder
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2021.696387
- 6,857 views
- 16 citations
Original Research
Published on 02 Nov 2021
Central Hypoventilation Is a Key Risk Factor for Mechanical Ventilation During the Acute Phase of Anti-N-Methyl-D-Aspartate Receptor Encephalitis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2021.728594
- 2,398 views
- 4 citations
Original Research
Published on 02 Nov 2021
Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Generalized Myasthenia Gravis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2021.696385
- 9,261 views
- 20 citations
Original Research
Published on 02 Nov 2021
Development and Internal Validation of a Disability Algorithm for Multiple Sclerosis in Administrative Data
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2021.754144
- 3,507 views
- 10 citations
Original Research
Published on 29 Oct 2021
Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2021.727586
- 3,618 views
- 7 citations
Case Report
Published on 29 Oct 2021
Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2021.785180
- 4,014 views
- 3 citations
Case Report
Published on 28 Oct 2021
Case Report: Amphiphysin Antibody-Associated Stiff-Limb Syndrome and Myelopathy: An Unusual Presentation of Breast Cancer in an Elderly Woman
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2021.735895
- 6,478 views
- 7 citations
Original Research
Published on 27 Oct 2021
Monocyte to High-Density Lipoprotein Ratio: A Novel Predictive Marker of Disease Severity and Prognosis in Patients With Neuromyelitis Optica Spectrum Disorders
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2021.763793
- 2,690 views
- 3 citations
Original Research
Published on 26 Oct 2021
C-Reactive Protein Levels and Gadolinium-Enhancing Lesions Are Associated With the Degree of Depressive Symptoms in Newly Diagnosed Multiple Sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2021.719088
- 12,204 views
- 5 citations
Original Research
Published on 26 Oct 2021
Clinical, Neurophysiological, and MRI Markers of Fampridine Responsiveness in Multiple Sclerosis—An Explorative Study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2021.758710
- 4,029 views
- 3 citations
Case Report
Published on 22 Oct 2021
Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2021.765954
- 61,239 views
- 50 citations
Case Report
Published on 22 Oct 2021
Case Report: A False Negative Case of Anti-Yo Paraneoplastic Myelopathy
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2021.728700
- 5,012 views
- 3 citations
Policy and Practice Reviews
Published on 21 Oct 2021
Clinical Pathway for the Diagnosis and Management of Patients With Relapsing–Remitting Multiple Sclerosis: A First Proposal for the Peruvian Population
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2021.667398
- 4,856 views
- 3 citations
Original Research
Published on 20 Oct 2021
Effectiveness of Natalizumab in Achieving No Evidence of Disease Activity (NEDA-3)—Data From a Local Norwegian Cohort
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2021.765837
- 2,922 views
- 4 citations
Systematic Review
Published on 20 Oct 2021
Serum Aquaporin 4-Immunoglobulin G Titer and Neuromyelitis Optica Spectrum Disorder Activity and Severity: A Systematic Review and Meta-Analysis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2021.746959
- 6,256 views
- 23 citations